Merck News company blog

Antiviral Molnupiravir Reduces Risk of Hospitalization/Death by ~50 Percent

merck.com published 2021-10-01

At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared With 14.1 Percent of Placebo-Treated Patients Who were Hospitalized or Died Merck Plans to Seek Emergency Use Authorization in the U.S. as Soon as Possible and to Submit Applications to Regulatory…

Points

206

HN comments

270

Submissions

1

Cited by

0 commenters

Science & SpaceTech Industry & Business2021

Related posts from the same era

Mechanical Watch

Bartosz Ciechanowski20224,298 points704 commentscited by 59 details

Sound

Bartosz Ciechanowski20223,053 points238 commentscited by 8 details

GPS

Bartosz Ciechanowski20222,900 points320 commentscited by 32 details

Gears

Bartosz Ciechanowski20202,760 points227 commentscited by 11 details

Internal Combustion Engine

Bartosz Ciechanowski20212,333 points498 commentscited by 16 details

Cameras and Lenses

Bartosz Ciechanowski20202,132 points269 commentscited by 10 details